Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sofia R Gameiro

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Cells

NPJ breast cancer

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Apr 1o 2008

United States

Staff scientist :: Laboratory of Tumor Immunology and Biology

Publications

Grace Lui, Christine M Minnar, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. Cells 12 (12) (2023)
S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian, Kristen Solocinski, Paul L Chariou, Duane H Hamilton, Joshua T Kowalczyk, Michelle R Padget, Sofia R Gameiro, Jeffrey Schlom, James W Hodge
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer immunology, immunotherapy : CII (2023)
Grace Lui, Christine M Minnar, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. Cells 12 (12) (2023)
Grace Lui, Christine M Minnar, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies. Cells 12 (12) (2023)
Christine M Minnar, Paul L Chariou, Lucas A Horn, Kristin C Hicks, Claudia Palena, Jeffrey Schlom, Sofia R Gameiro
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies. Journal for immunotherapy of cancer 10 (6) (2022)
Sofia R Gameiro, Julius Strauss, James L Gulley, Jeffrey Schlom
Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status. Experimental biology and medicine (Maywood, N.J.) 247 (13) (2022)
Karin M Knudson, Kristin C Hicks, Yohei Ozawa, Jeffrey Schlom, Sofia R Gameiro
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist. Journal for immunotherapy of cancer 8 (1) (2021)
Kristin C Hicks, Paul L Chariou, Yohei Ozawa, Christine M Minnar, Karin M Knudson, Thomas J Meyer, Jing Bian, Margaret Cam, Jeffrey Schlom, Sofia R Gameiro
Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape. Nature communications 12 (1) (2021)
Yohei Ozawa, Kristin C Hicks, Christine M Minnar, Karin M Knudson, Jeffrey Schlom, Sofia R Gameiro
Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa. Oncoimmunology 10 (1) (2021)
Karin M Knudson, James W Hodge, Jeffrey Schlom, Sofia R Gameiro
Rationale for IL-15 superagonists in cancer immunotherapy. Expert opinion on biological therapy 20 (7) (2020)
Kristin C Hicks, Karin M Knudson, Karin L Lee, Duane H Hamilton, James W Hodge, William Douglas Figg, Peter Ordentlich, Frank R Jones, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Karin L Lee, Stephen Charles Benz, Kristin C Hicks, Andrew Nguyen, Sofia R Gameiro, Claudia Palena, John Z Sanborn, Zhen Su, Peter Ordentlich, Lars Rohlin, John H Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, Kayvan Niazi, Jeffrey Schlom, Duane H Hamilton
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy. Cancer immunology research 7 (8) (2019)
David B Page, Harry Bear, Sangeetha Prabhakaran, Margaret E Gatti-Mays, Alexandra Thomas, Erin Cobain, Heather McArthur, Justin M Balko, Sofia R Gameiro, Rita Nanda, James L Gulley, Kevin Kalinsky, Julia White, Jennifer Litton, Steven J Chmura, Mei-Yin Polley, Benjamin Vincent, David W Cescon, Mary L Disis, Joseph A Sparano, Elizabeth A Mittendorf, Sylvia Adams
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer. NPJ breast cancer 5 (2019)
Margaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, Harry D Bear, Sangeetha Prabhakaran, Jami Fukui, Mary L Disis, Rita Nanda, James L Gulley, Kevin Kalinsky, Houssein Abdul Sater, Joseph A Sparano, David W Cescon, David B Page, Heather McArthur, Sylvia Adams, Elizabeth A Mittendorf
If we build it they will come: targeting the immune response to breast cancer. NPJ breast cancer 5 (2019)

Sofia R Gameiro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sofia R Gameiro